TMC Pharma Services Ltd

TMC Pharma Services Ltd is a United Kingdom-based company that specializes in providing a wide range of expert support services to the pharmaceutical industry. With a focus on combining traditional CRO services with full support for all activities in the pre-, peri-, and post-marketing setting, TMC has established itself as a key player in the industry since its founding in 2000. The company's highly qualified team has a strong track record in delivering successful projects across several key areas, including drug development from preclinical to post approval, regulatory affairs, drug development consultancy, and post approval/marketing support. Their hands-on approach to problem-solving demonstrates their commitment to tackling the unique challenges that each project presents. In August 2022, TMC Pharma Services Ltd received a significant £18.00M investment in a Private Equity Round, with LDC participating as the investor. This investment further underscores the company's potential for growth and innovation within the biotechnology, health care, and pharmaceutical sectors. Overall, TMC Pharma Services Ltd's comprehensive services, strong industry presence, and recent investment signify its commitment to driving progress and creating value within the pharmaceutical industry, positioning it as a promising investment opportunity for venture capitalists.